- Licensed space at 7ACRES increases to 230,000 sqft.
- Target annual production capacity is estimated to increase by 28% to approximately 33,580kg.
- Supreme Cannabis expects to submit additional rooms for Health Canada approval in the near term.
TORONTO, May 13, 2019 – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its wholly-owned subsidiary, 7ACRES, has obtained Health Canada approval for five additional flowering rooms totalling 50,000 sqft of additional production space at its facility in Kincardine, Ontario.
Total flowering room space at 7ACRES increases from 180,000 sqft to 230,000 sqft and 7ACRES’ annual production capacity estimate increases from approximately 26,250kg to 33,580kg. As noted previously, Supreme Cannabis expects to realize further production efficiencies following the licensing of all 25 flowering rooms, whereby 7ACRES’ potential capacity is anticipated to reach approximately 50,000kg.
“With five more flowering rooms at 7ACRES now approved by Health Canada, the finish line is in sight,” said John Fowler, President and Founder of Supreme Cannabis. “As 7ACRES continues to work towards full production capacity, we are excited to fulfil demand for our high-end cannabis from enthusiasts coast-to-coast.”